Thoratec Comments on Publication of HeartMate II® Bridge-to-Transplantation Post-Approval Study in JACC
DATA SHOW SURVIVAL OF 90 PERCENT AT SIX MONTHS AND MEANINGFUL REDUCTION IN ADVERSE EVENTS PLEASANTON, Calif., May 3, 2011 /PRNewswire/ — Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today commented on an article published in the Journal of the American College […]
Read More »Category : Press Releases
Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film
JERSEY CITY, N.J., May 2, 2011 /PRNewswire/ — Aoxing Pharmaceutical (NYSE Amex: AXN) (“Aoxing Pharma”), a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, announced that its operating subsidiary in China, Hebei Aoxing Pharmaceutical Group Company, has been granted a patent by the State Intellectual Property Office of […]
Read More »Category : Press Releases
Cyberonics Announces First Implant of AspireSRâ„¢ Seizure Response Product in European Trial
HOUSTON, May 2, 2011 /PRNewswire/ — Cyberonics, Inc. (Nasdaq: CYBX), a global leader in epilepsy management, today announced the first implant of its AspireSRâ„¢ seizure response product on April 27, 2011. The implant, conducted under the care of Professors Paul Boon and Dirk Van Roost and their teams at the Ghent University Epilepsy Group in […]
Read More »Category : Press Releases
Affinium Pharmaceuticals, Ltd., Announces Results of AFN-1252 Multiple Ascending Dose Phase I Clinical Trial
AUSTIN, TEXAS, May 2 /PRNewswire/ – Affinium Pharmaceuticals announced today the results of a new multiple ascending dose Phase I study of its novel, selective-spectrum, anti-staphylococcal agent, AFN-1252 in a novel oral formulation. The study examined the tolerability, safety and pharmacokinetics of immediate release tablets of AFN-1252. Cohorts of healthy volunteers were dosed 200mg, 300mg, […]
Read More »Category : Press Releases
AquaStar Holdings, Inc.’s Client Receives U.S. Patent 7,708,944 for Portable Capillary Sensor Technology
AquaStar Holdings, Inc. (Pink Sheets: RPPR) is pleased to announce that the United States Patent and Trademark Office has issued patent number 7,708,944 for the Ultra-Sensitive, Portable Capillary Sensor technology utilized by the Capwave Enzyme-Linked Immuno-Sorbent Assay (ELISA) platform. The patent, entitled “Ultra-Sensitive, Portable Capillary Sensor” details research completed at the State University of New […]
Read More »Category : Press Releases
OncoMed Pharmaceuticals Announces FDA Clearance to Commence Phase 1 Testing of Anti-Cancer Stem Cell Therapeutic OMP-18R5
OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells or tumor-initiating cells, today announced that the FDA has accepted an IND filing for OMP-18R5, which allows OncoMed to commence Phase 1 clinical testing. OMP-18R5 is a monoclonal antibody that binds selected receptors in the Wnt signaling pathway and is the first […]
Read More »Category : Press Releases
Patient Advocates File FOIA Request to FDA on Avastin
WASHINGTON, April 27, 2011 /PRNewswire/ — Leaders in the battle with the U.S. Food and Drug Administration to retain metastatic breast cancer (mbc) as an indication for the drug Avastin today filed a Freedom of Information Act (“FOIA”) request with the FDA. The filers include noted attorney David Rivkin, partner at the law firm Baker […]
Read More »Category : Press Releases
Taro Resolves FDA Warning Letter
Taro Pharmaceutical Industries Ltd. (“Taro†or the “Companyâ€, Pink Sheets: TAROF) today announced that the U.S. Food and Drug Administration (“FDAâ€) has informed the Company that after a February 2011 re-inspection of its Canadian manufacturing facility, the site has an acceptable regulatory status. Therefore, the issues noted in the February 5, 2009 warning letter are […]
Read More »Category : Press Releases
BistroMD’s Founding Physician Explains Why Alcohol Consumption Is a Factor in Nation’s Growing Obesity Epidemic
NAPLES, Fla., April 26, 2011 /PRNewswire/ — With April marking National Alcohol Awareness Month, Caroline J. Cederquist, M.D. shares new evidence that shows America’s alcohol consumption is contributing to the nation’s growing obesity epidemic. “Alcoholic beverages give us a fake sense of feeling full,” says Dr. Cederquist. “Scientific studies show that when we drink alcoholic […]
Read More »Category : Press Releases
Lilly and Medtronic Announce Drug-Device Collaboration for Parkinson’s Disease
INDIANAPOLIS and MINNEAPOLIS, April 26, 2011 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Medtronic, Inc. (NYSE: MDT) today announced they have entered into a collaboration to research and develop a new approach to treating Parkinson’s disease that involves delivering a potential new medicine to the brain using an implantable drug delivery system. The […]
Read More »Category : Press Releases
